Trial Profile
Post Marketing Surveillance on Long Drug Use of Micombi Combination Tablets in Patients With Hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jun 2014
Price :
$35
*
At a glance
- Drugs Telmisartan/hydrochlorothiazide (Primary)
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 29 Jan 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 02 May 2012 Actual patient number 1412 to 1434 added as reported by ClinicalTrials.gov.
- 04 Apr 2012 Actual patient number 1412 added as reported by ClinicalTrials.gov.